Efficient risk-based collection of biospecimens in cohort studies: designing a prospective study of diagnostic performance for multicancer detection tests
American Journal of Epidemiology · 2025
DOI: 10.1093/aje/kwae139 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Mark Louie F Ramos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Beth…. Hauptthemen laut MEDLINE: Specimen Handling, Lung Neoplasms, Early Detection of Cancer, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural Research Program of the US National Institutes of Health, NIH.
Abstract (Originalsprache)
In cohort studies, it can be infeasible to collect specimens on an entire cohort. For example, to estimate sensitivity of multiple multi-cancer detection (MCD) assays, we desire an extra 80 mL of cell-free DNA (cfDNA) blood, but this much extra blood is too expensive for us to collect on everyone. We propose a novel epidemiologic study design that efficiently oversamples those at highest baseline disease risk from whom to collect specimens, to increase the number of future cases with cfDNA blood collection. The variance reduction ratio from our risk-based subsample versus a simple random (sub)sample (SRS) depends primarily on the ratio of risk model sensitivity to the fraction of the cohort selected for specimen collection subject to constraining the risk model specificity. In a simulation where we chose 34% of the Prostate, Lung, Colorectal, and Ovarian Screening Trial cohort at highest risk of lung cancer for cfDNA blood collection, we could enrich the number of lung cancers 2.42-fold. The standard deviation of lung-cancer MCD sensitivity was 31%-33% reduced versus SRS. Risk-based collection of specimens on a subsample of the cohort could be a feasible and efficient approach to collecting extra specimens for molecular epidemiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, United States.
ORCID-Profile: Mark Louie F Ramos, Anil K Chaturvedi, Barry I Graubard, Hormuzd A Katki
Förderung
- Intramural Research Program of the US National Institutes of Health
- NIH
Zitieren
APA
Ramos, M. L. F., Chaturvedi, A. K., Graubard, B. I., & Katki, H. A. (2025). Efficient risk-based collection of biospecimens in cohort studies: designing a prospective study of diagnostic performance for multicancer detection tests. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae139
Vancouver
Ramos MLF, Chaturvedi AK, Graubard BI, Katki HA. Efficient risk-based collection of biospecimens in cohort studies: designing a prospective study of diagnostic performance for multicancer detection tests. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae139
BibTeX
@article{Ramos2025,
author = {Ramos, Mark Louie F and Chaturvedi, Anil K and Graubard, Barry I and Katki, Hormuzd A},
title = {Efficient risk-based collection of biospecimens in cohort studies: designing a prospective study of diagnostic performance for multicancer detection tests},
journal = {American Journal of Epidemiology},
year = {2025},
doi = {10.1093/aje/kwae139}
}
EUVIMED